OFG
WST icon

OmniStar Financial Group’s West Pharmaceutical WST Stock Holding History

OmniStar Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Buy
+629
New +$192K 0.1% 106
2020
Q2 		– Sell
-100
Closed -$15K – 309
2020
Q1 		$15K Buy
+100
New +$15.4K 0.01% 200

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

OmniStar Financial Group's WST Position: Q2 2026 in Review

OmniStar Financial Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 629 shares worth $226K. The stake represents 0.1% of the portfolio and ranks #106 among its holdings. This is a return to the name: OmniStar Financial Group previously reported a position in WST as recently as Q1 2020.

OmniStar Financial Group first reported a position in WST in Q1 2020 and has held it in 2 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • OmniStar Financial Group held 629 shares of West Pharmaceutical worth $226K as of Q2 2026.
  • West Pharmaceutical was a new OmniStar Financial Group position in Q2 2026.
  • West Pharmaceutical made up 0.1% of OmniStar Financial Group's portfolio in Q2 2026, its #106 holding.
  • OmniStar Financial Group first reported a position in West Pharmaceutical in Q1 2020 and has held it in 2 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.